| Acceptance No. | Drug Name | Active Ingredient | Dosage Form | Classification | Submission | Acceptance Date | Manufacturers | Manufacturers | Review Status | Status Date | View |
|---|---|---|---|---|---|---|---|---|---|---|---|
| CXSL1900004 | 重组抗TNF-α全人源单克隆抗体注射液 | adalimumab | Injection | Biological Products(2) | New Drug Application | 2019-01-21 | 广东东阳光生物制剂有限公司 | Guangdong HEC Bio&Pharm Co Ltd | In Review | 2019-01-18 | view |